Cargando…
A Safety and Efficacy Study of Medium-Dose Etoposide, Cyclophosphamide and Total Body Irradiation Conditioning Before Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia
Prognosis for adult patients with acute lymphoblastic leukemia (ALL) has been reported to be approximately 35% to 50%, even after allogeneic stem cell transplantation (allo-SCT). We previously reported retrospective analyses of a conditioning regimen of medium-dose etoposide, cyclophosphamide (CY),...
Autores principales: | Shigematsu, Akio, Ozawa, Yukiyasu, Onizuka, Makoto, Fujisawa, Shin, Suzuki, Ritsuro, Atsuta, Yoshiko, Hatanaka, Kazuo, Masuko, Masayoshi, Ito, Toshiro, Kobayashi, Naoki, Kato, Jun, Miyamura, Koichi, Fukuda, Takahiro, Morishima, Yasuo, Imamura, Masahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946459/ https://www.ncbi.nlm.nih.gov/pubmed/27500214 http://dx.doi.org/10.1097/TXD.0000000000000514 |
Ejemplares similares
-
Allogeneic hematopoietic stem cell transplantation in adult acute lymphoblastic leukemia: potential benefit of medium-dose etoposide conditioning
por: Imamura, Masahiro, et al.
Publicado: (2015) -
Perspectives on the Use of a Medium-Dose Etoposide, Cyclophosphamide, and Total Body Irradiation Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation: The Japanese Experience from 1993 to Present
por: Imamura, Masahiro, et al.
Publicado: (2019) -
Pharmacokinetics and dose adjustment of etoposide administered in a medium-dose etoposide, cyclophosphamide and total body irradiation regimen before allogeneic hematopoietic stem cell transplantation
por: Tazawa, Yuki, et al.
Publicado: (2016) -
CMV reactivation after allogeneic HCT is associated with a reduced risk of relapse in acute lymphoblastic leukemia
por: Akahoshi, Yu, et al.
Publicado: (2023) -
Poor outcome of allogeneic transplantation for therapy-related acute myeloid leukemia induced by prior chemoradiotherapy
por: Araie, Hiroaki, et al.
Publicado: (2023)